Potential signaling pathway of hypoxia-inducible factor in lung cancer and its gene polymorphism with lung cancer risk

References

• Cote ML, Liu M, Bonassi S, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer 2012;48:1957–68
   PubMed Web of Science ®Google Scholar
• Uso M, Jantus-Lewintre E, Sirera R, et al. miRNA detection methods and clinical implications in lung cancer. Future Oncol 2014;10:2279–92
   PubMed Web of Science ®Google Scholar
• Feng X, Qin JJ, Zheng BS, et al. Association of epidermal growth factor receptor (EGFR) gene polymorphism with lung cancer risk: a systematic review. J Recept Signal Transduct Res 2014;34:333–4
   PubMed Web of Science ®Google Scholar
• Feng X, Zheng BS, Shi JJ, et al. Association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer. Mol Biol Rep 2012;39:10313–23
   PubMed Web of Science ®Google Scholar
• Zhou HF, Feng X, Zheng BS, et al. A meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer including 31802 subjects. Mol Biol Rep 2013;40:5713–21
   PubMed Web of Science ®Google Scholar
• Chu X, Zhu CC, Liu H, Wang JC. Expression of hypoxia-inducible factor prolyl hydroxylase 3 HIFPH3 in human non-small cell lung cancer (NSCLC) and its correlation with prognosis. Asian Pac J Cancer Prev 2014;15:5819–23
   PubMed Web of Science ®Google Scholar
• Shepardson KM, Jhingran A, Caffrey A, et al. Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection. PLoS Pathog 2014;10:e1004378
   PubMedGoogle Scholar
• Lu QL, Liu J, Zhu XL, Xu WJ. Expression of nerve growth factor and hypoxia inducible factor-1alpha and its correlation with angiogenesis in non-small cell lung cancer. J Huazhong Univ Sci Technolog Med Sci 2014;34:359–62
   PubMed Web of Science ®Google Scholar
• Yohena T, Yoshino I, Takenaka T, et al. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer. J Thorac Oncol 2009;4:284–90
   PubMed Web of Science ®Google Scholar
• Jian H, Liu B, Zhang J. Hypoxia and hypoxia-inducible factor 1 repress SEMA4B expression to promote non-small cell lung cancer invasion. Tumour Biol 2014;35:4949–55
   PubMed Web of Science ®Google Scholar
• Liang J, Qian Y, Xu D, et al. Serum tumor markers, hypoxia-inducible factor-1alpha HIF-1alpha and vascular endothelial growth factor, in patients with non-small cell lung cancer before and after intervention. Asian Pac J Cancer Prev 2013;14:3851–4
   PubMed Web of Science ®Google Scholar
• Karetsi E, Ioannou MG, Kerenidi T, et al. Differential expression of hypoxia-inducible factor 1alpha in non-small cell lung cancer and small cell lung cancer. Clinics (Sao Paulo) 2012;67:1373–8
   PubMed Web of Science ®Google Scholar
• Wu XH, Qian C, Yuan K. Correlations of hypoxia-inducible factor-1alpha/hypoxia-inducible factor-2alpha expression with angiogenesis factors expression and prognosis in non-small cell lung cancer. Chin Med J (Engl) 2011;124:11–18
   PubMed Web of Science ®Google Scholar
• Lin HH, Tsai CW, Chou FP, et al. Andrographolide down-regulates hypoxia-inducible factor-1alpha in human non-small cell lung cancer A549 cells. Toxicol Appl Pharmacol 2011;250:336–45
   PubMed Web of Science ®Google Scholar
• Park S, Ha SY, Cho HY, et al. Prognostic implications of hypoxia-inducible factor-1alpha in epidermal growth factor receptor-negative non-small cell lung cancer. Lung Cancer 2011;72:100–7
   PubMed Web of Science ®Google Scholar
• Xu L, Nilsson MB, Saintigny P, et al. Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells. Oncogene 2010;29:2616–27
   PubMed Web of Science ®Google Scholar
• Hu MD, Xu JC, Fan Y, et al. Hypoxia-inducible factor 1 promoter-induced JAB1 overexpression enhances chemotherapeutic sensitivity of lung cancer cell line A549 in an anoxic environment. Asian Pac J Cancer Prev 2012;13:2115–20
   PubMed Web of Science ®Google Scholar
• Guo L, Li L, Wang W, et al. Mitochondrial reactive oxygen species mediates nicotine-induced hypoxia-inducible factor-1alpha expression in human non-small cell lung cancer cells. Biochim Biophys Acta 2012;1822:852–61
   PubMed Web of Science ®Google Scholar
• Zhang Q, Tang X, Zhang ZF, et al. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res 2007;13:4686–94
   PubMed Web of Science ®Google Scholar
• Schilling D, Bayer C, Li W, et al. Radiosensitization of normoxic and hypoxic h1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1alpha. PLoS One 2012;7:e31110
   PubMed Web of Science ®Google Scholar
• Li G, Xie B, Li X, et al. Down-regulation of survivin and hypoxia-inducible factor-1 alpha by beta-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft. Cancer Biother Radiopharm 2012;27:56–64
   PubMed Web of Science ®Google Scholar
• Wang MJ, Lin S. A region within the 5′-untranslated region of hypoxia-inducible factor-1alpha mRNA mediates its turnover in lung adenocarcinoma cells. J Biol Chem 2009;284:36500–10
   PubMed Web of Science ®Google Scholar
• Zhu XX, Guo Y, Chen LH, Ding YQ. Expressions of metastatic tumor antigen 1 and hypoxia-inducible-factor l alpha in lung cancer and their clinical significance. Nan Fang Yi Ke Da Xue Xue Bao 2009;29:642–4
   PubMedGoogle Scholar
• Kim WY, Oh SH, Woo JK, et al. Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha. Cancer Res 2009;69:1624–32
   PubMed Web of Science ®Google Scholar
• Wangpaichitr M, Savaraj N, Maher J, et al. Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines. Mol Cancer Ther 2008;7:1506–13
   PubMed Web of Science ®Google Scholar
• Shyu KG, Hsu FL, Wang MJ, et al. Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion. Exp Cell Res 2007;313:1181–91
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang H. Hypoxia-inducible factor-1alpha suppressing apoptosis and increasing tolerance of lung cancer cells to chemotherapy. J Huazhong Univ Sci Technolog Med Sci 2006;26:520–3
   PubMedGoogle Scholar
• Liu YL, Yu JM, Song XR, et al. Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines. Cancer Biol Ther 2006;5:1320–6
   PubMed Web of Science ®Google Scholar
• Phillips RJ, Mestas J, Gharaee-Kermani M, et al. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem 2005;280:22473–81
   PubMed Web of Science ®Google Scholar
• Litz J, Krystal GW. Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells. Mol Cancer Ther 2006;5:1415–22
   PubMed Web of Science ®Google Scholar
• Csiki I, Yanagisawa K, Haruki N, et al. Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer. Cancer Res 2006;66:143–50
   PubMed Web of Science ®Google Scholar
• Hirami Y, Aoe M, Tsukuda K, et al. Relation of epidermal growth factor receptor, phosphorylated-Akt, and hypoxia-inducible factor-1alpha in non-small cell lung cancers. Cancer Lett 2004;214:157–64
   PubMed Web of Science ®Google Scholar
• Swinson DE, Jones JL, Cox G, et al. Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer 2004;111:43–50
   PubMed Web of Science ®Google Scholar
• Zhang HL, Zhang ZX, Xu YJ. Hypoxia-inducible factor-1 alpha increased the expression of peroxisome proliferator activated receptor alpha in lung cancer cell A549. Chin Med J (Engl) 2004;117:145–7
   PubMed Web of Science ®Google Scholar
• Zhou TB, Drummen GP, Jiang ZP, et al. Association of peroxisome proliferator-activated receptors/retinoic acid receptors with renal diseases. J Recept Signal Transduct Res 2013;33:349–52
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH, Su LN, et al. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst 2011;12:624–33
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH, Su LN, et al. ACE I/D gene polymorphism can't predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: a meta-analysis. PLoS One 2011;6:e19599
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS, Jiang ZP. Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease. J Recept Signal Transduct Res 2013;33:325–31
   PubMed Web of Science ®Google Scholar
• Putra AC, Tanimoto K, Arifin M, Hiyama K. Hypoxia-inducible factor-1alpha polymorphisms are associated with genetic aberrations in lung cancer. Respirology 2011;16:796–802
   PubMed Web of Science ®Google Scholar
• Kuo WH, Shih CM, Lin CW, et al. Association of hypoxia inducible factor-1alpha polymorphisms with susceptibility to non-small-cell lung cancer. Transl Res 2012;159:42–50
   PubMed Web of Science ®Google Scholar